125 related articles for article (PubMed ID: 12172507)
1. Efficacy and tolerability of an aminopterin-albumin conjugate in tumor-bearing rats.
Kremer P; Hartung G; Bauder-Wüst U; Schrenk HH; Wunder A; Heckl S; Zillmann U; Sinn H
Anticancer Drugs; 2002 Jul; 13(6):615-23. PubMed ID: 12172507
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of methotrexate-albumin conjugates in rats bearing a Walker-256 carcinoma.
Wunder A; Stehle G; Schrenk HH; Hartung G; Heene DL; Maier-Borst W; Sinn H
Int J Cancer; 1998 Jun; 76(6):884-90. PubMed ID: 9626357
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of methotrexate-albumin conjugates in tumor-bearing rats.
Stehle G; Wunder A; Sinn H; Schrenk HH; Schütt S; Frei E; Hartung G; Maier-Borst W; Heene DL
Anticancer Drugs; 1997 Oct; 8(9):835-44. PubMed ID: 9402310
[TBL] [Abstract][Full Text] [Related]
4. The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in rats.
Stehle G; Sinn H; Wunder A; Schrenk HH; Schütt S; Maier-Borst W; Heene DL
Anticancer Drugs; 1997 Aug; 8(7):677-85. PubMed ID: 9311444
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate-albumin and aminopterin-albumin effectively prevent experimental acute graft-versus-host disease.
Wolff D; Frei E; Hofmeister N; Steiner B; Kleine HD; Junghanss C; Sievert K; Terpe H; Schrenk HH; Freund M; Hartung G
Transplantation; 2006 Aug; 82(4):527-33. PubMed ID: 16926597
[TBL] [Abstract][Full Text] [Related]
6. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.
Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
Anticancer Drugs; 1999 Sep; 10(8):785-90. PubMed ID: 10573211
[TBL] [Abstract][Full Text] [Related]
7. Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression.
Wang ES; O'Connor O; She Y; Zelenetz AD; Sirotnak FM; Moore MA
Leuk Lymphoma; 2003 Jun; 44(6):1027-35. PubMed ID: 12854905
[TBL] [Abstract][Full Text] [Related]
8. Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivo.
Burger AM; Hartung G; Stehle G; Sinn H; Fiebig HH
Int J Cancer; 2001 Jun; 92(5):718-24. PubMed ID: 11340578
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate-albumin conjugate causes tumor growth delay in Dunning R3327 HI prostate cancer-bearing rats.
Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
Anticancer Drugs; 1999 Apr; 10(4):405-11. PubMed ID: 10378676
[TBL] [Abstract][Full Text] [Related]
10. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate.
Pinard MF; Jolivet J; Ratnam M; Kathmann I; Molthoff C; Westerhof R; Schornagel JH; Jansen G
Cancer Chemother Pharmacol; 1996; 38(3):281-8. PubMed ID: 8646804
[TBL] [Abstract][Full Text] [Related]
11. Further evidence for a basis of selective activity and relative responsiveness during antifolate therapy of murine tumors.
Sirotnak FM; Donsback RC
Cancer Res; 1975 Jul; 35(7):1737-44. PubMed ID: 1169115
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W
Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
[TBL] [Abstract][Full Text] [Related]
13. Anticancer antifolates: current status and future directions.
McGuire JJ
Curr Pharm Des; 2003; 9(31):2593-613. PubMed ID: 14529544
[TBL] [Abstract][Full Text] [Related]
14. New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1985 May; 69(5):551-3. PubMed ID: 4005878
[TBL] [Abstract][Full Text] [Related]
15. A new analogue of 10-deazaaminopterin with markedly enhanced curative effects against human tumor xenografts in mice.
Sirotnak FM; DeGraw JI; Colwell WT; Piper JR
Cancer Chemother Pharmacol; 1998; 42(4):313-8. PubMed ID: 9744777
[TBL] [Abstract][Full Text] [Related]
16. A case for the use of aminopterin in treatment of patients with leukemia based on metabolic studies of blasts in vitro.
Smith A; Hum M; Winick NJ; Kamen BA
Clin Cancer Res; 1996 Jan; 2(1):69-73. PubMed ID: 9816092
[TBL] [Abstract][Full Text] [Related]
17. Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemia.
Cole PD; Drachtman RA; Masterson M; Smith AK; Glod J; Zebala JA; Lisi S; Drapala DA; Kamen BA
Cancer Chemother Pharmacol; 2008 Jun; 62(1):65-75. PubMed ID: 17768625
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate and aminopterin exhibit similar in vitro and in vivo preclinical activity against acute lymphoblastic leukaemia and lymphoma.
Kang MH; Harutyunyan N; Hall CP; Papa RA; Lock RB
Br J Haematol; 2009 May; 145(3):389-93. PubMed ID: 19298590
[TBL] [Abstract][Full Text] [Related]
19. A novel methotrexate-albumin (mtx-rsa)-conjugate causes significant growth delay of o-342 ovarian-carcinoma in-vivo.
Steinmann A; Friedrich E; Rath U
Oncol Rep; 1995 Jan; 2(1):107-9. PubMed ID: 21597699
[TBL] [Abstract][Full Text] [Related]
20. Activity of the folate analog 10-ethyl, 10-deaza-aminopterin (10-EdAM) against human head and neck cancer xenografts.
Brown DH; Braakhuis BJ; van Dongen GA; van Walsum M; Bagnay M; Snow GB
Anticancer Res; 1989; 9(6):1549-52. PubMed ID: 2627109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
